These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34439122)

  • 1. Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Candido JB; Maiques O; Boxberg M; Kast V; Peerani E; Tomás-Bort E; Weichert W; Sananes A; Papo N; Magdolen V; Sanz-Moreno V; Loessner D
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.
    Bouzid H; Soualmia F; Oikonomopoulou K; Soosaipillai A; Walker F; Louati K; Lo Dico R; Pocard M; El Amri C; Ignatenko NA; Darmoul D
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.
    Goldhardt O; Warnhoff I; Yakushev I; Begcevic I; Förstl H; Magdolen V; Soosaipillai A; Diamandis E; Alexopoulos P; Grimmer T
    Transl Neurodegener; 2019; 8():25. PubMed ID: 31467673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.
    Ahmed N; Dorn J; Napieralski R; Drecoll E; Kotzsch M; Goettig P; Zein E; Avril S; Kiechle M; Diamandis EP; Schmitt M; Magdolen V
    Biol Chem; 2016 Dec; 397(12):1265-1276. PubMed ID: 27483364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
    Grin A; Samaan S; Tripathi M; Rotondo F; Kovacs K; Bassily MN; Yousef GM
    Hum Pathol; 2015 Apr; 46(4):541-8. PubMed ID: 25649006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis.
    Nathalie HV; Chris P; Serge G; Catherine C; Benjamin B; Claire B; Christelle P; Briollais L; Pascale R; Marie-Lise J; Yves C
    J Cell Mol Med; 2009 Sep; 13(9B):4014-22. PubMed ID: 19426157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A KLK6 Activity-Based Probe Reveals a Role for KLK6 Activity in Pancreatic Cancer Cell Invasion.
    Zhang L; Lovell S; De Vita E; Jagtap PKA; Lucy D; Goya Grocin A; Kjær S; Borg A; Hennig J; Miller AK; Tate EW
    J Am Chem Soc; 2022 Dec; 144(49):22493-22504. PubMed ID: 36413626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
    Tailor PD; Kodeboyina SK; Bai S; Patel N; Sharma S; Ratnani A; Copland JA; She JX; Sharma A
    Oncotarget; 2018 Apr; 9(25):17876-17888. PubMed ID: 29707153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy.
    Komatsu N; Saijoh K; Kuk C; Shirasaki F; Takehara K; Diamandis EP
    Br J Dermatol; 2007 May; 156(5):875-83. PubMed ID: 17459012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-silico analysis of kallikrein gene expression in pancreatic and colon cancers.
    Yousef GM; Borgoño CA; Popalis C; Yacoub GM; Polymeris ME; Soosaipillai A; Diamandis EP
    Anticancer Res; 2004; 24(1):43-51. PubMed ID: 15015574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma.
    Rückert F; Hennig M; Petraki CD; Wehrum D; Distler M; Denz A; Schröder M; Dawelbait G; Kalthoff H; Saeger HD; Diamandis EP; Pilarsky C; Grützmann R
    Br J Cancer; 2008 Nov; 99(9):1484-92. PubMed ID: 18854834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
    Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A
    Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing variant of kallikrein-related peptidase 8 as an independent predictor of unfavorable prognosis in lung cancer.
    Planque C; Choi YH; Guyetant S; Heuzé-Vourc'h N; Briollais L; Courty Y
    Clin Chem; 2010 Jun; 56(6):987-97. PubMed ID: 20360129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation.
    Ni T; Zhao RH; Wu JF; Li CY; Xue G; Lin X
    Biochem Genet; 2024 Dec; 62(6):4446-4471. PubMed ID: 38316654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
    Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.
    Christodoulou S; Alexopoulou DK; Kontos CK; Scorilas A; Papadopoulos IN
    Tumour Biol; 2014 May; 35(5):4673-85. PubMed ID: 24430362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
    White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ
    Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein-related peptidases in lung diseases.
    Lenga Ma Bonda W; Iochmann S; Magnen M; Courty Y; Reverdiau P
    Biol Chem; 2018 Sep; 399(9):959-971. PubMed ID: 29604204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients.
    Komatsu N; Saijoh K; Kuk C; Liu AC; Khan S; Shirasaki F; Takehara K; Diamandis EP
    Exp Dermatol; 2007 Jun; 16(6):513-9. PubMed ID: 17518992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.